- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
SK Bioscience Co Ltd (302440)
SK Bioscience Co Ltd stock price live, this page displays KS 302440 stock exchange data. View the 302440 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the SK Bioscience Co Ltd real time stock price chart below.
What Is the SK Bioscience Co Ltd Stock Price Today?
The SK Bioscience Co Ltd stock price today is 51,500.
What Is the Stock Symbol for SK Bioscience Co Ltd?
The stock symbol for SK Bioscience Co Ltd is ""302440.""
What Stock Exchange Does SK Bioscience Co Ltd Trade On?
SK Bioscience Co Ltd is listed and trades on the Seoul stock exchange.
Is SK Bioscience Co Ltd a Good Stock to Buy?
Determining whether SK Bioscience Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 302440 quote. (ISIN: KR7302440003)
What Is the SK Bioscience Co Ltd Stock Price Today?
The SK Bioscience Co Ltd stock price today is 51,500.
What Is the Stock Symbol for SK Bioscience Co Ltd?
The stock symbol for SK Bioscience Co Ltd is ""302440.""
What Stock Exchange Does SK Bioscience Co Ltd Trade On?
SK Bioscience Co Ltd is listed and trades on the Seoul stock exchange.
Is SK Bioscience Co Ltd a Good Stock to Buy?
Determining whether SK Bioscience Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 302440 quote. (ISIN: KR7302440003)
Seoul
Currency in KRW
51,500
-300(-0.58%)
Closed·
Fair Value
An estimate of a SK Bioscience Co's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
50,500
52,200
52 wk Range
35,800
61,300
Earnings results expected in 7 days
1/2
Fair Value
An estimate of a SK Bioscience Co's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
50,50052,200
52 wk Range
35,80061,300
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
302440 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a SK Bioscience Co's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
40,400
Downside
-21.55%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- SK Bioscience Co receives Investment Bank Analyst Rating Update
- Investing.com
Pro - SK Bioscience Co receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- SK Bioscience Co receives Investment Bank Analyst Rating Update
- Investing.com
Pro - SK Bioscience Co receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
SK Bioscience Co Ltd Company Profile
SK bioscience Co.,Ltd. engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally. Its product portfolio includes Skycellflu, a cell cultured influenza surface antigen vaccine; Skycellflu 4-ga pre-filled syringe; pneumococcal vaccine for adult and infant; Skyzoster, a shingles virus vaccine; and Sky Baricella for the prevention of chickenpox infection in children. The company also engages in the development of oral rotavirus vaccine that has completed phase 2 clinical trial; cervical cancer vaccine, which has completed phase 2 clinical trial; rotavirus vaccine that is in phase 3 clinical trial in Africa; typhoid conjugate vaccine; and Corona 19 vaccine that is in phase 1 and phase 1/2 clinical trials; and low-cost pneumococcal vaccine, which has completed phase 2 clinical trial and next-generation pneumococcal vaccine that is in phase 2 clinical trial in the United States. SK bioscience Co.,Ltd. was founded in 2018 and is based in Seongnam-si, South Korea. SK bioscience Co.,Ltd. is a subsidiary of SK Chemicals Co.,Ltd.
Compare 302440 to Peers and Sector
Metrics to compare | 302440 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship302440PeersSector | |
|---|---|---|---|---|
P/E Ratio | −688.7x | −12.9x | −0.6x | |
PEG Ratio | −7.94 | −0.21 | 0.00 | |
Price/Book | 2.2x | 3.5x | 2.6x | |
Price / LTM Sales | 6.5x | 17.4x | 3.4x | |
Upside (Analyst Target) | −17.0% | −21.1% | 41.7% | |
Fair Value Upside | Unlock | 7.0% | 5.0% | Unlock |
Analyst Ratings
0 Buy
3 Hold
3 Sell
Ratings:
6 analysts
Overall Consensus
Sell
Analysts 12-Month Price Target:
Average 40,400
(-21.55% Downside)
Earnings
Latest Release
Nov 03, 2025
EPS / Forecast
268.98 / -372.19
Revenue / Forecast
151.00B / 170.00B
People Also Watch
FAQ
What Stock Exchange Does SK Bioscience Co Trade On?
SK Bioscience Co is listed and trades on the Seoul Stock Exchange stock exchange.
What Is the Stock Symbol for SK Bioscience Co?
The stock symbol for SK Bioscience Co is "302440."
What Is the SK Bioscience Co Market Cap?
As of today, SK Bioscience Co market cap is 4.06T.
What Is SK Bioscience Co's Earnings Per Share (TTM)?
The SK Bioscience Co EPS (TTM) is -75.30.
When Is the Next SK Bioscience Co Earnings Date?
SK Bioscience Co will release its next earnings report on 02 Feb 2026.
From a Technical Analysis Perspective, Is 302440 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has SK Bioscience Co Stock Split?
SK Bioscience Co has split 0 times.
How Many Employees Does SK Bioscience Co Have?
SK Bioscience Co has 917 employees.
What is the current trading status of SK Bioscience Co (302440)?
As of 27 Jan 2026, SK Bioscience Co (302440) is trading at a price of 51,500, with a previous close of 51,800. The stock has fluctuated within a day range of 50,500 to 52,200, while its 52-week range spans from 35,800 to 61,300.
What Is SK Bioscience Co (302440) Price Target According to Analysts?
The average 12-month price target for SK Bioscience Co is KRW40,400, with a high estimate of KRW55000 and a low estimate of KRW25000. 0 analysts recommend buying the stock, while 3 suggest selling, leading to an overall rating of Sell. The stock has an -21.55% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.